Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-15

Clinical Trial Update: A Randomized, Controlled, Cross-Over Trial of Safety of Vaginal Use of Carraguard by HIV-Infected Women [Phase 1]

View source ↗

Summary

Phase 1 randomized cross-over study assessing the safety of vaginal Carraguard gel in HIV-infected women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carraguard

Snippet

Sponsor: Population Council | Conditions: HIV Infections | Phase 1 | Status: COMPLETED